Advertisement
Canada markets open in 3 hours 1 minute
  • S&P/TSX

    22,107.08
    +194.56 (+0.89%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CAD/USD

    0.7353
    -0.0019 (-0.26%)
     
  • CRUDE OIL

    81.94
    +0.59 (+0.73%)
     
  • Bitcoin CAD

    95,662.96
    +285.36 (+0.30%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,220.30
    +7.60 (+0.34%)
     
  • RUSSELL 2000

    2,114.35
    +44.19 (+2.13%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,492.25
    -11.50 (-0.06%)
     
  • VOLATILITY

    12.97
    +0.19 (+1.49%)
     
  • FTSE

    7,959.79
    +27.81 (+0.35%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6815
    +0.0010 (+0.15%)
     

Delta 9 Provides Guidance & Timing for Q2 2021 Results

WINNIPEG, Manitoba, June 22, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”) is pleased to provide guidance on its revenue forecast for the three-month and six-month period ending June 30, 2021 based on preliminary results:

  • The Company anticipates revenue for the three-month period ending June 30, 2021 to be between $15.5 million and $17.25 million compared with;

    • $13.23 million for the first quarter of 2021.

    • $13.01 million for the second quarter of 2020.

  • Delta 9 anticipates revenues for the six-month period ending June 30, 2021 to be between $28.75 million and $30.5 million, compared to:

    • $24.76 million for the same period last year

“We anticipate our Q2, 2021 performance will demonstrate a record revenue quarter for Delta 9 with the Company’s three business segments contributing to the success of the quarter,” said John Arbuthnot, CEO of Delta 9. “We anticipate continued growth in all three of our business segments units through the back half of 2021.”

The Company will provide investors with a full breakdown of revenue and financial results as part of it’s Financial Statements and Management Discussion and Analysis for the three-month and six-month period ending June 30, 2021. A news release on the financials will be issued on August 16, 2021, before the stock market opens. This will be followed by a conference call the same morning, the details of which can be found at the end of this release.

ADVERTISEMENT

The preliminary estimated revenues for the three-month and six-month period ended June 30, 2021 set forth above are subject to the completion of the Company's financial closing procedures. These preliminary estimated financial results have been prepared by and are the responsibility of the Company's management.

The Company currently expects that its final results for revenue will be consistent with the estimates set forth above, but such estimates are preliminary and the Company’s actual results of operations and other data could differ materially from these estimates due to the completion of its financial closing procedures, final adjustments and other developments that may arise between now and the time such consolidated financial statements for the period ended June 30, 2021 are issued.

2021 Second Quarter Results Conference Call

Delta 9 will release the results for the second quarter of 2021 on August 16, 2021 before the market opens. A conference call to discuss the above results is scheduled for the morning of August 16, 2021, pre-market. The conference call will be hosted that day at 9:00 a.m. Eastern Time by John Arbuthnot, Chief Executive Officer, and Jim Lawson, Chief Financial Officer, followed by a question-and-answer period.

DATE:

August 16, 2021

TIME:

9:00 am Eastern Time

Dial in #

1-888-886-7786


REPLAY:


1-877-674-6060
Available until 12:00 midnight Eastern Time, November 17, 2021


Replay passcode:

949425 #

For more information contact:

Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
Mobile: 204-898-7722
E-mail: ian.chadsey@delta9.ca

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol “DLTNF”. For more information, please visit www.delta9.ca.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to Delta 9’s financial results for the quarter ended June 30, 2021. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including the Company’s actual financial results being different from its estimates as well as all risk factors set forth in the annual information form of Delta 9 dated March 31, 2021 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.